Aphria Inc. Common Shares (APHA): Price and Financial Metrics
Aphria Inc. Common Shares (APHA)
Today's Latest Price: $5.27 USD
0.08 (1.54%)
Updated Jan 17 12:00am
Add APHA to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 213 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
APHA Stock Summary
- Aphria Inc's stock had its IPO on November 2, 2018, making it an older stock than just 0.67% of US equities in our set.
- With a year-over-year growth in debt of 1,471.7%, Aphria Inc's debt growth rate surpasses 97.82% of about US stocks.
- Revenue growth over the past 12 months for Aphria Inc comes in at 542.28%, a number that bests 98.73% of the US stocks we're tracking.
- Stocks that are quantitatively similar to APHA, based on their financial statements, market capitalization, and price volatility, are AM, OR, EOLS, ADES, and NBEV.
- Visit APHA's SEC page to see the company's official filings. To visit the company's web site, go to www.aphria.ca.
APHA Daily Price Range
APHA 52-Week Price Range
APHA Stock Price Chart More Charts
APHA Price/Volume Stats
| Current price | $5.27 | 52-week high | $10.95 |
| Prev. close | $5.19 | 52-week low | $3.76 |
| Day low | $5.08 | Volume | 6,649,800 |
| Day high | $5.33 | Avg. volume | 7,350,633 |
| 50-day MA | $4.85 | Dividend yield | N/A |
| 200-day MA | $6.14 | Market Cap | 1.33B |
Aphria Inc. Common Shares (APHA) Company Bio
Aphria, Inc. engages in the production and supply of medical marijuana. Its products include alien dawg, champlian indica, grower's blend, champlain-sativa and blueberry. The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada.
Top Stories View All
3 Vital Investing Strategies
Best & Worst Performing Stock Industries for January 17, 2020
Best & Worst Performing Small Cap Stocks for January 17, 2020
Best & Worst Performing Mid Cap Stocks for January 17, 2020
Best & Worst Performing Large Cap Stocks for January 17, 2020
View All Top Stories
Loading social stream, please wait...